Inflammatory Bowel Disease I: Ulcerative Colitis
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Cancer Survival Analysis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Miwa Hirai1, Yasuhiro Kanatani2, Takashi Ueda1
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan.
Ulcerative colitis (UC) patients have increased colorectal cancer (CRC) risk. Pseudo-polyps and dysplasia are key risk factors, while 5-ASA may reduce risk. Machine learning identified pancolitis and proctitis as significant indicators for CRC development.
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: